Suppr超能文献

技术进步是否能改善手术结果?达芬奇标准型/ S型/ Si型与Xi机器人平台在机器人肾输尿管切除术期间的比较。

Does Advancing Technology Improve Outcomes? Comparison of the Da Vinci Standard/S/Si to the Xi Robotic Platforms During Robotic Nephroureterectomy.

作者信息

Patel Manish N, Hemal Ashok K

机构信息

1 Department of Urology, Wake Forest University , Winston-Salem, North Carolina.

2 Department of Urology, Wake Forest University Baptist Medical Center , Winston-Salem, North Carolina.

出版信息

J Endourol. 2018 Feb;32(2):133-138. doi: 10.1089/end.2017.0477.

Abstract

INTRODUCTION

With the introduction of laparoscopy and now robotics, more patients are able to reap benefit from minimally invasive techniques during urologic surgery. With these advancing technologies, it is important to evaluate whether the outlay of hospital capital actually improves patient care. To date, there has been little literature regarding the impact of these advances on patient outcomes. In this article, we directly compare perioperative outcomes and hospital costs between the older da Vinci Standard/S/Si platform and the newer Xi robotic platform during nephroureterectomy.

METHODS

A review of our robotic nephroureterectomy database between April 2009 and December 2017 identified 87 patients, 30 in group 1 (Xi) and 57 in group 2 (Standard/S/Si). Preoperative, perioperative, and postoperative parameters as well as hospital costs were evaluated. Independent t-test was performed for continuous variables, while categorical variables were evaluated using chi-square tests or Fisher's exact test.

RESULTS

There were no significant differences between groups preoperatively. Operative time using the Xi was shorter, 184.4 vs 232.09 minutes (p = 0.0035). Other perioperative variables were similar. There was more lymphovascular invasion in group 2 (p = 0.0108), but there were higher stage tumors in group 1 (p < 0.0001). More patients underwent lymph node dissection in group 1 (p = 0.0186). Complications were similar between groups. Costs for anesthesia were less in group 1, which led to decreased total hospitalization costs (p < 0.001) Conclusion: Operative times were found to be less with the daVinci Xi, without any other significant difference in patient outcomes between the groups. Anesthesia and operating room cost were substantial factors in lowering the overall hospital costs. More multi-institutional studies with larger groups of patients are needed to determine if advancing technology really improves outcomes.

摘要

引言

随着腹腔镜技术以及如今机器人技术的引入,越来越多的患者能够在泌尿外科手术中从微创技术中获益。随着这些技术的不断进步,评估医院资本投入是否真的改善了患者护理变得很重要。迄今为止,关于这些进展对患者预后影响的文献很少。在本文中,我们直接比较了在肾输尿管切除术期间,较旧的达芬奇标准/S/Si平台与较新的Xi机器人平台的围手术期结果和医院成本。

方法

回顾我们2009年4月至2017年12月期间的机器人辅助肾输尿管切除术数据库,确定了87例患者,其中第1组(Xi)30例,第2组(标准/S/Si)57例。评估术前、围手术期和术后参数以及医院成本。对连续变量进行独立t检验,分类变量使用卡方检验或Fisher精确检验进行评估。

结果

术前两组之间无显著差异。使用Xi的手术时间较短,为184.4分钟,而另一组为232.09分钟(p = 0.0035)。其他围手术期变量相似。第2组有更多的淋巴管侵犯(p = 0.0108),但第1组有更高分期的肿瘤(p < 0.0001)。第1组有更多患者接受了淋巴结清扫(p = 0.0186)。两组之间的并发症相似。第1组的麻醉费用较低,这导致总住院费用降低(p < 0.001)结论:发现达芬奇Xi的手术时间较短,两组之间患者预后无任何其他显著差异。麻醉和手术室成本是降低总体医院成本的重要因素。需要更多涉及更大患者群体的多机构研究来确定技术进步是否真的改善了预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验